Health minister JP Nadda has highlighted a grave issue facing India: the alarming rise in cancer cases, which are increasing by approximately 2.5% annually. Addressing the Lok Sabha, Nadda stressed the government's relentless efforts to ensure that cancer patients receive affordable and accessible treatment amidst this growing crisis.

Nadda revealed that the number of cancer cases is staggering, with more than 15.5 lakh new cases being registered every year. Among men, oral and lung cancers are becoming more prevalent, while breast cancer rates are surging among women. This escalating trend underscores the urgent need for effective healthcare interventions.

In response to this crisis, the government has implemented stringent measures to control the pricing of essential cancer medicines. A list of 131 vital cancer drugs, included in Schedule 1, is under strict price regulation. These medicines are commonly used in cancer treatment, and the price controls have led to significant savings for patients, amounting to approximately ₹294 crore. Additionally, the National Pharmaceutical Pricing Authority (NPPA) and the government have extended price controls to 28 other combinations of cancer medicines not listed in Schedule 1.

Recognizing the critical shortage of healthcare professionals, Nadda also announced the expansion of medical colleges to increase the number of doctors available to meet the rising demand for cancer treatment. The government's comprehensive approach aims to alleviate the burden on cancer patients and ensure that life-saving treatments remain within reach for all those affected by this devastating disease.
For more interesting updates wa click and follow Indiaherald WhatsApp channel

Find out more:

Sindujaa D N

26/07/2024 04:01 PM